Hindustan Unilever is currently trading at Rs. 1829.95, up by 76.35 points or 4.35% from its previous closing of Rs. 1753.60 on the BSE.
The scrip opened at Rs. 1779.90 and has touched a high and low of Rs. 1833.40 and Rs. 1746.50 respectively. So far 203714 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1,833.40 on 03-Dec-2018 and a 52 week low of Rs. 1241.30 on 04-Dec-2017.
Last one week high and low of the scrip stood at Rs. 1,833.40 and Rs. 1678.00 respectively. The current market cap of the company is Rs. 393814.58 crore.
The promoters holding in the company stood at 67.19%, while Institutions and Non-Institutions held 19.42% and 13.39 % respectively.
Hindustan Unilever (HUL) has received approval for scheme of amalgamation with GlaxoSmithKline Consumer Healthcare (GSKCH) and their respective shareholders and creditors. The Board of Directors of the company at their meeting held on December 03, 2018, approved the same.
GSKCH is the one of the key players in the Foods and Refreshment (F&R) category with iconic brands such as Horlicks and Boost and comprises a wide product portfolio. The proposed amalgamation of GSKCH business with the company is in line with the strategy to build a sustainable and profitable Foods and Refreshments (F&R) business in India. The parties expect significant synergies through supply chain opportunities and operational improvements, go-to-market and distribution network optimisation, scale efficiencies in cost areas such as marketing, and optimisation of overlapping infrastructure.
HUL is India’s largest Fast Moving Consumer Goods Company with a heritage of over 80 years in India and touches the lives of nine out of ten Indian households.
| Company Name | CMP |
|---|---|
| Hindustan Unilever | 2241.10 |
| Godrej Consumer Prod | 1108.20 |
| Dabur India | 442.10 |
| Colgate Palmol. (I) | 2106.20 |
| P&G Hygiene | 10006.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: